Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial.

Changcheng Tao,Fan Wu,Hongwei Wang,Liming Wang,Yue Liu,Anke Wu,Linlin Zheng,Yaru Wang,Bo Chen,Weiqi Rong,Jianxiong Wu

Journal of hepatocellular carcinoma（2023）

引用 0|浏览13

暂无评分

摘要

Liver resection combined with neoadjuvant radiotherapy was effective and safe for treatment of centrally located HCC patients, which improved the prognosis of patients and reduced the incidence of early recurrence.

查看译文

关键词

centrally located hepatocellular carcinoma,hepatocellular carcinoma,neoadjuvant radiotherapy,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要